Senior Manager, Regulatory Affairs
Avalyn Pharmaceuticals
This listing was originally posted on Avalyn Pharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAbout Avalyn:
Avalyn aims to transform the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases. The company is advancing optimized inhaled formulations of established antifibrotic medicines designed to deliver drug directly to the lungs, enhance local efficacy, and reduce systemic side effects. Avalyn’s AP01 program is an optimized inhaled formulation of pirfenidone currently being evaluated in MIST, a global Phase 2b clinical trial in patients with progressive pulmonary fibrosis (PPF). AP01 has demonstrated encouraging safety and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone. Avalyn’s AP02 program is an optimized inhaled formulation of nintedanib currently being evaluated in AURA-IPF, a global Phase 2 clinical trial in patients with idiopathic pulmonary fibrosis (IPF). Avalyn is also advancing AP03, an inhaled fixed-dose combination of pirfenidone and nintedanib, designed to deliver multiple antifibrotic mechanisms through a single lung-targeted platform. By leveraging its proprietary drug-device approach and deep expertise in rare respiratory disease development, Avalyn aims to establish a new standard of care in pulmonary fibrosis through inhaled, lung-targeted therapies. For more information, please visit avalynpharma.com and follow the company on LinkedIn.
Position Summary:
The Senior Manager, Regulatory Affairs will support the development and execution of the global regulatory strategy and execution for Avalyn’s development-stage, inhaled drug-device combination products. Reporting to the SVP, Regulatory Affairs, this position will contribute to global regulatory submissions, health authority interactions, and cross-functional regulatory planning to support product development activities. This role is well suited for a highly motivated regulatory professional who is looking to expand their regulatory leadership capabilities while supporting programs from early stages through late-phase clinical development.
The Senior Manager will primarily support senior regulatory leadership in the planning and execution of regulatory activities across the development pipeline. The role will contribute to regulatory initiatives that promote consistency, operational excellence, and compliance across programs, including support for regulatory processes, systems, and standards. As experience and responsibilities grow, the individual will have the opportunity to assume increasing ownership of an assigned development program under guidance of senior regulatory leadership. This position will work collaboratively across functions to help ensure high-quality regulatory deliverables and effective interactions with global health authorities.
Responsibilities:
Strategic & Regulatory Program Support
Regulatory Filings & Health Authority Interactions
Regulatory Operations, Systems, & Compliance
Cross-Functional Collaboration & Team Contribution
Qualifications:
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Avalyn Pharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Therapies for the treatment of Idiopathic Pulmonary Fibrosis
Upgrade to Pro to access all 8 linked drug products and competitive data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo